查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1764263

2025年双磷酸盐全球市场报告

Bisphosphonates Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年双磷酸盐市场规模将强劲成长。至2029年，该市场规模将成长至70.7亿美元，复合年增长率为5.5%。预测期内的增长可归因于骨骼健康研究投入的增加、对可负担的骨质疏鬆症治疗的需求增长、对老年医疗保健的日益关注、双磷酸盐在新兴市场的使用不断扩大，以及数字健康宣传活动带来的认知度不断提高。预计这段时期的主要趋势包括药物传递系统的创新、具有更高生物有效性的先进製剂、联合治疗的开发、患者依从性技术的进步以及个人化治疗方法的进步。

骨质疏鬆症盛行率的上升预计将在未来几年推动双磷酸盐市场的成长。骨质疏鬆症是一种使骨骼变得脆弱并更容易骨折的疾病。骨质疏鬆症的主要原因是全球人口老化、生活习惯和缺乏适当的预防措施，因为骨骼密度会随着老龄化的增长而降低。双磷酸盐可有效治疗骨质疏鬆症，透过减缓骨骼分解来强化骨骼和降低骨折风险。例如，2024 年 8 月，专注于骨骼健康研究和倡导的组织「澳洲健康骨骼」报告称，2023 年预计将有 193,482 例与骨质疏鬆症和骨质缺乏症相关的骨折，预计到 2033 年将增加 34%，达到 237,632 例。因此，骨质疏鬆症盛行率的上升是推动双磷酸盐市场成长的关键因素。

预计未来几年，越来越多的研究和临床试验将推动双磷酸盐市场的成长。临床试验是对人类受试者进行的研究，旨在评估新治疗方法、药物和医疗设备的安全性、有效性和潜在副作用。这种增长很大程度上是由于对创新治疗方法的需求不断增长，以满足不断变化的医疗保健需求并改善患者预后。在双磷酸盐方面，临床研究透过检视治疗骨质疏鬆症和骨转移等疾病的有效性、安全性和长期效果，在推进骨骼健康治疗方面发挥关键作用。例如，2023 年 11 月，英国製药工业协会 (ABPI) 报告称，英国由产业主导的临床试验增加了 4.3%，从 2021 年的 394 项试验增加到 2022 年的 411 项试验。因此，对研究和临床试验的更多关注对双磷酸盐市场扩张做出了重大贡献。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球双磷酸盐：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球双磷酸盐市场：成长率分析
  • 全球双磷酸盐市场表现：规模与成长，2019-2024
  • 全球双磷酸盐市场预测：2024-2029 年及 2034 年规模与成长
  • 全球双磷酸盐：总目标市场（TAM）

第六章市场区隔

  • 全球双磷酸盐市场类型、绩效及预测（2019-2024、2024-2029、2034）
  • 阿崙膦酸钠
  • Ibandronate sodium
  • 利塞膦酸盐
  • Zoledronic acid
  • 全球双磷酸盐市场（依给药途径、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 静脉
  • 皮下
  • 骨内
  • 肌肉注射
  • 全球双磷酸盐市场（依通路、绩效及预测）2019-2024、2024-2029、2034
  • 医院药房
  • 零售药局
  • 网路药局
  • 其他的
  • 全球双磷酸盐市场应用、绩效及预测（2019-2024、2024-2029、2034）
  • 骨质疏鬆症
  • 柏哲氏病
  • 骨转移
  • 其他的
  • 全球双磷酸盐市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 居家照护
  • 医药零售
  • 全球双磷酸盐市场、阿崙膦酸盐细分市场、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 口服锭剂
  • 每週配方
  • 与维生素 D 结合
  • 非专利阿崙膦酸盐
  • 全球双磷酸盐市场、Ibandronate sodium酸盐细分市场、按类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 口服锭剂
  • 每月口服剂型
  • 静脉注射
  • 非专利Ibandronate sodium
  • 全球双磷酸盐市场、利塞膦酸盐细分市场、按类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 速释片
  • 延迟释放片
  • 每周和每月剂量
  • 与钙结合
  • 全球双磷酸盐市场、Zoledronic acid细分市场、按类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 静脉输液
  • 年剂量
  • 在肿瘤学的应用
  • 用于骨质疏鬆症
  • 非专利Zoledronic acid

第七章 区域和国家分析

  • 全球双磷酸盐市场各地区、绩效及预测（2019-2024、2024-2029、2034）
  • 全球双磷酸盐市场（按国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 双磷酸盐市场：竞争格局
  • 双磷酸盐市场：公司简介
    • Pfizer Inc.
    • Roche Holding AG
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Bayer AG

第31章 其他大型创新企业

  • Novartis AG
  • Eli Lilly and Company
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Organon & Co.
  • Sun Pharmaceutical Industries Ltd.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Ltd.
  • Alkem Laboratories
  • Natco Pharma Ltd.
  • Strides Pharma Science Limited
  • Radius Health Inc.
  • Warner Chilcott

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年双磷酸盐市场：提供新机会的国家
  • 2029 年双磷酸盐市场：细分市场带来新机会
  • 2029 年双磷酸盐市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35851

Bisphosphonates are a group of drugs that help prevent bone loss by inhibiting the activity of osteoclasts, making them a primary therapy for osteoporosis and other bone-weakening conditions. They are frequently prescribed to lower the risk of fractures in individuals with low bone density, Paget's disease, or bone metastases due to cancer. These medications aid in strengthening bones, increasing bone mineral density, and reducing fracture risk, especially in postmenopausal women and older adults.

The major types of bisphosphonates include alendronate, ibandronate, risedronate, and zoledronic acid. Alendronate is specifically used to treat and prevent bone-related disorders such as osteoporosis and Paget's disease. These drugs can be administered through various routes, including oral, intravenous, subcutaneous, intraosseous, and intramuscular. They are available through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels. Primary applications include treating osteoporosis, Paget's disease, and bone metastases, with end users ranging from hospitals and clinics to homecare settings and pharmaceutical retailers.

The bisphosphonates market research report is one of a series of new reports from The Business Research Company that provides bisphosphonates market statistics, including bisphosphonates industry global market size, regional shares, competitors with a bisphosphonates market share, detailed bisphosphonates market segments, market trends and opportunities, and any further data you may need to thrive in the bisphosphonates industry. This bisphosphonates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bisphosphonates market size has grown strongly in recent years. It will grow from $5.39 billion in 2024 to $5.70 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the increasing incidence of multiple myeloma, a rise in glucocorticoid-induced osteoporosis cases, the prevalence of sedentary lifestyles, greater availability of generic bisphosphonates, and the growing use of these medications in treating metastatic bone disease.

The bisphosphonates market size is expected to see strong growth in the next few years. It will grow to $7.07 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The projected growth in the forecast period can be attributed to increased investment in bone health research, rising demand for affordable osteoporosis treatments, a growing emphasis on elderly healthcare, expanding use of bisphosphonates in emerging markets, and heightened awareness driven by digital health campaigns. Key trends expected during this period include innovations in drug delivery systems, advanced formulations with enhanced bioavailability, the development of combination therapies, advancements in patient adherence technologies, and progress in personalized treatment approaches.

The rising prevalence of osteoporosis is expected to drive the growth of the bisphosphonates market in the coming years. Osteoporosis is a medical condition marked by weakened bones that are more susceptible to fractures. Its growing prevalence is mainly attributed to the aging global population, as bone density naturally declines with age, along with contributing lifestyle factors and a lack of adequate preventive measures. Bisphosphonates are effective in treating osteoporosis by slowing bone degradation, thereby strengthening bones and lowering fracture risk. For example, in August 2024, Healthy Bones Australia, an organization focused on bone health research and advocacy, reported that in 2023, there were an estimated 193,482 fractures linked to osteoporosis and osteopenia, with projections indicating a 34% increase to 237,632 fractures by 2033. Thus, the rising incidence of osteoporosis is a key factor fueling the growth of the bisphosphonates market.

The rise in research and clinical trials is expected to drive the growth of the bisphosphonates market in the coming years. Clinical trials are research studies involving human participants that assess the safety, effectiveness, and potential side effects of new treatments, drugs, or medical devices. This increase is largely fueled by the growing demand for innovative therapies to meet evolving healthcare needs and enhance patient outcomes. In the context of bisphosphonates, clinical research plays a critical role in advancing bone health treatments by examining their efficacy, safety, and long-term impact in managing conditions like osteoporosis and bone metastases. For example, in November 2023, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported a 4.3% increase in industry-initiated clinical trials in the UK, rising from 394 trials in 2021 to 411 in 2022. Thus, the growing focus on research and clinical trials is contributing significantly to the expansion of the bisphosphonates market.

In May 2023, Abiogen Pharma S.p.A., an Italy-based pharmaceutical company, acquired EffRx Pharmaceuticals SA for an undisclosed amount. This acquisition is intended to strategically enhance and diversify Abiogen's rare disease portfolio by incorporating EffRx's innovative therapies for musculoskeletal and rare conditions. It also supports Abiogen's goal of expanding its international footprint and strengthening its capabilities in the development and commercialization of specialized treatments worldwide. EffRx Pharmaceuticals SA is a Switzerland-based specialty pharmaceutical company that produces and markets bisphosphonates for the treatment of osteoporosis.

Major players in the bisphosphonates market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Organon & Co., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Natco Pharma Ltd., Strides Pharma Science Limited, Radius Health Inc., Warner Chilcott.

North America was the largest region in the bisphosphonates market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bisphosphonates report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bisphosphonates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bisphosphonates market consists of sales of oral tablets, bisphosphonate capsules, bisphosphonate injections, oral solutions, and intravenous (IV) infusions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bisphosphonates Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bisphosphonates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bisphosphonates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bisphosphonates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
  • 2) By Route Of Administration: Oral; Intravenous; Subcutaneous; Intraosseous; Intramuscular
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • 4) By Application: Osteoporosis; Paget's Disease; Bone Metastasis; Other Application
  • 5) By End-User: Hospitals; Clinics; Homecare Settings; Pharmaceutical Retail
  • Subsegments:
  • 1) By Alendronate: Oral Tablets; Once-Weekly Formulation; Combination With Vitamin D; Generic Alendronate
  • 2) By Ibandronate: Oral Tablets; Monthly Oral Formulation; Intravenous Injection; Generic Ibandronate
  • 3) By Risedronate: Immediate-Release Tablets; Delayed-Release Tablets; Weekly And Monthly Dosing; Combination With Calcium
  • 4) By Zoledronic Acid: Intravenous Infusion; Annual Dosing; Oncology Use; Osteoporosis Use; Generic Zoledronic Acid
  • Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bisphosphonates Market Characteristics

3. Bisphosphonates Market Trends And Strategies

4. Bisphosphonates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bisphosphonates Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bisphosphonates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bisphosphonates Market Growth Rate Analysis
  • 5.4. Global Bisphosphonates Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bisphosphonates Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bisphosphonates Total Addressable Market (TAM)

6. Bisphosphonates Market Segmentation

  • 6.1. Global Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alendronate
  • Ibandronate
  • Risedronate
  • Zoledronic Acid
  • 6.2. Global Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Intravenous
  • Subcutaneous
  • Intraosseous
  • Intramuscular
  • 6.3. Global Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.4. Global Bisphosphonates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Osteoporosis
  • Paget's Disease
  • Bone Metastasis
  • Other Application
  • 6.5. Global Bisphosphonates Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare Settings
  • Pharmaceutical Retail
  • 6.6. Global Bisphosphonates Market, Sub-Segmentation Of Alendronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets
  • Once-Weekly Formulation
  • Combination With Vitamin D
  • Generic Alendronate
  • 6.7. Global Bisphosphonates Market, Sub-Segmentation Of Ibandronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets
  • Monthly Oral Formulation
  • Intravenous Injection
  • Generic Ibandronate
  • 6.8. Global Bisphosphonates Market, Sub-Segmentation Of Risedronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immediate-Release Tablets
  • Delayed-Release Tablets
  • Weekly And Monthly Dosing
  • Combination With Calcium
  • 6.9. Global Bisphosphonates Market, Sub-Segmentation Of Zoledronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous Infusion
  • Annual Dosing
  • Oncology Use
  • Osteoporosis Use
  • Generic Zoledronic Acid

7. Bisphosphonates Market Regional And Country Analysis

  • 7.1. Global Bisphosphonates Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bisphosphonates Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bisphosphonates Market

  • 8.1. Asia-Pacific Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bisphosphonates Market

  • 9.1. China Bisphosphonates Market Overview
  • 9.2. China Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bisphosphonates Market

  • 10.1. India Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bisphosphonates Market

  • 11.1. Japan Bisphosphonates Market Overview
  • 11.2. Japan Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bisphosphonates Market

  • 12.1. Australia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bisphosphonates Market

  • 13.1. Indonesia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bisphosphonates Market

  • 14.1. South Korea Bisphosphonates Market Overview
  • 14.2. South Korea Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bisphosphonates Market

  • 15.1. Western Europe Bisphosphonates Market Overview
  • 15.2. Western Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bisphosphonates Market

  • 16.1. UK Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bisphosphonates Market

  • 17.1. Germany Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bisphosphonates Market

  • 18.1. France Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bisphosphonates Market

  • 19.1. Italy Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bisphosphonates Market

  • 20.1. Spain Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bisphosphonates Market

  • 21.1. Eastern Europe Bisphosphonates Market Overview
  • 21.2. Eastern Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bisphosphonates Market

  • 22.1. Russia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bisphosphonates Market

  • 23.1. North America Bisphosphonates Market Overview
  • 23.2. North America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bisphosphonates Market

  • 24.1. USA Bisphosphonates Market Overview
  • 24.2. USA Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bisphosphonates Market

  • 25.1. Canada Bisphosphonates Market Overview
  • 25.2. Canada Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bisphosphonates Market

  • 26.1. South America Bisphosphonates Market Overview
  • 26.2. South America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bisphosphonates Market

  • 27.1. Brazil Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bisphosphonates Market

  • 28.1. Middle East Bisphosphonates Market Overview
  • 28.2. Middle East Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bisphosphonates Market

  • 29.1. Africa Bisphosphonates Market Overview
  • 29.2. Africa Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bisphosphonates Market Competitive Landscape And Company Profiles

  • 30.1. Bisphosphonates Market Competitive Landscape
  • 30.2. Bisphosphonates Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Bisphosphonates Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Eli Lilly and Company
  • 31.3. Amgen Inc.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Organon & Co.
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. Apotex Inc.
  • 31.8. Aurobindo Pharma Ltd.
  • 31.9. Dr. Reddy's Laboratories Ltd.
  • 31.10. Cipla Ltd.
  • 31.11. Alkem Laboratories
  • 31.12. Natco Pharma Ltd.
  • 31.13. Strides Pharma Science Limited
  • 31.14. Radius Health Inc.
  • 31.15. Warner Chilcott

32. Global Bisphosphonates Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bisphosphonates Market

34. Recent Developments In The Bisphosphonates Market

35. Bisphosphonates Market High Potential Countries, Segments and Strategies

  • 35.1 Bisphosphonates Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bisphosphonates Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bisphosphonates Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer